T1	Outcomes 0 27	Safety and pharmacokinetics
T2	Outcomes 792 823	the safety and pharmacokinetics
T3	Outcomes 1099 1122	The mean FVIIa activity
T4	Outcomes 1233 1262	The pharmacokinetics of N7-GP
T5	Outcomes 1314 1327	investigated.
T6	Outcomes 1328 1387	No serious adverse events (including thromboembolic events)
T7	Outcomes 1403 1434	The frequency of adverse events
T8	Outcomes 1485 1525	No neutralizing antibodies against N7-GP
T9	Outcomes 1541 1563	A pharmacologic effect
T10	Outcomes 1637 1662	the mean prothrombin time
